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Background: Malnutrition affects 1/3 of hemodialysis patients and associates with a higher risk of morbidity and
mortality. Serum albumin is a marker of nutrition and inflammation, and predicts mortality, particularly when
<3.8 g/dL. This study was performed to identify risk factors for hypoalbuminemia (<3.8 g/dL) and the particular
temporal relationship and strength of association between protein intake (nPCR) and serum albumin when
confounding variables are taken into account.
Methods: Demographic, clinical, and dialysis-related data of 57 ESRD patients on hemodialysis over 24 months in 6
temporal segments were analyzed with serum albumin as a continuous, and categorical outcome (with 3.8 g/dl as
cut-off) variable , against 13 potential independent variables [4 demographic factors, 3 nutrition-related, and 5
morbidity-related parameters, and % urea reduction ratio (URR)]. The temporal relationships between albumin and
nPCR were analyzed for the concurrent & 3 subsequent months in each temporal segment.
Results: The impact of nPCR on serum albumin (p < 0.05) was significant but with no discernible temporal
relationship. Advancing age, longer vintage, female gender, diabetes mellitus, nPCR, serum phosphate and ferritin
had significant correlation with albumin <3.8 g/dl (p < 0.05). Serum phosphate levels correlated positively, and fever,
bacteremia, hospital stay and weight loss negatively, with mean serum albumin but did not negate the effect of
nPCR. Regression analysis showed that mean albumin associated with nPCR, fever, hospital stay, bacteremia, dialysis
vintage, age, sex, and diabetes mellitus; and that an albumin level of <3.8 g/dl associated with age, female sex,
diabetes, lower nPCR, and higher ferritin.
Conclusion: Suggested target albumin levels were not met in elderly, female, and diabetic patients. The association
of nPCR with albumin was not nullified by confounding demographic or morbidity-related factors. nPCR had no
demonstrable temporal relationship with albumin.Background
370,274 U.S residents received maintenance hemodialysis
in 2009 [1]. The expected life span is 20 – 25 years shorter
for dialyzed patients than for age, sex, and race – matched
U.S. controls over 45 years of age [2]. Protein-energy
malnutrition is a major risk factor for mortality and in-
flammation; the presence of co-morbid conditions like
cardiovascular disease increases this risk further [3-7].* Correspondence: nsridhar@buffalomedicalgroup.com
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distribution, and reproduction in any mediumSerum albumin is a marker of nutrition and inflamma-
tion and predicts mortality [8-10]. Studies have suggested
that a serum albumin level of less than 3.8 g/dL (and/or
a reduction in serum albumin levels) confers a greater
mortality risk in patients with end-stage renal disease
(ESRD) [11,12] and in various other disease states [13].
Guidelines proposed by the Centers for Medicare and
Medicaid Services (CMS), Dialysis Outcomes Quality
Initiative (DOQI) and the International Society of
Nutrition Managers to maintain target serum albumin
levels in ESRD are >/= 3.5, 4.0, and 3.8 g/dl respectively
[10,14,15]. Serum albumin levels are considered indicators
of quality of care at some dialysis facilities and may be in-
cluded as a parameter of quality by the Centers forentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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large study of intra-dialytic parenteral nutrition (IDPN)
did not show a mortality benefit vis-à-vis oral supplements
[16]. In the present retrospective study, we tried to identify
factors associated with serum albumin and identify
risk factors for hypoalbuminemia (< 3.8 g/dL) using only
demographic and those biochemical measurements that
are routinely available in the United States; we were par-
ticularly interested in the temporal association between
nPCR (normalized protein catabolic rate) as an indicator
of protein intake and serum albumin over an extended
period of 24 consecutive months. Further, we tried to
understand whether this relationship between nPCR and
albumin was robust when the confounding effects of other
factors that appeared to correlate with albumin levels in
univariate analyses were taken into account.
Methods
The current study was undertaken at a single tertiary-
care hospital-based outpatient hemodialysis center with
about 100 patients during the study period of which
regular, uninterrupted, serum albumin levels and 10
other numerical variables were available for 57 patients
for 24 consecutive months (the remaining patients were
transferred to free-standing centers within a few months,
died, or received transplants) who gave signed informed
consent to have their data included in the study which
was approved by the University at Buffalo’s Institutional
Review Board. The inclusion criteria included patients
who were on maintenance hemodialysis from February
2008 to February 2010 and their ability to sign an in-
formed consent. Hemodialysis was performed three times
weekly in 55 patients and twice weekly in 2 patients. Low
flux dialyzers using modified cellulosic membranes were
used in all the patients. There were no major changes
made in the dialysis prescription during the two year
period except those pertaining to target weight, heparin,
and dialysate potassium concentration.
All patients had been advised to restrict total dietary
phosphate to between 1000 and 1500 mg per day. Food
diaries were not available for review.
A total of 10 patients had been dialyzed at this tertiary
hospital-based outpatient dialysis facility for longer
than 4 months but less than 24 months and were not
included.
The outcome variable, serum albumin, was measured
by the bromocresol purple method which gives slightly
lower values than the bromocresol green method.
Therefore a value of 3.8 g/dl which is 0.2 g/dl lower than
that suggested by K/DOQI was used for analysis; this is
0.3 g/dl higher than the target suggested by CMS. Age,
dialysis vintage in months, nPCR, serum phosphate, %
dry weight change, body temperature before, during, and
at closure of HD to enumerate the number of febrileepisodes if >37 degrees C, the number of episodes of
bacteremia, the number of days spent at any hospital
when the outpatient status of the patient was suspended,
and the % URR were used as continuous independent
variables. Patient-gender and diabetes mellitus were used
as categorical independent variables. All the laboratory
measurements were made by standard assay methods at
the clinical laboratories of Kaleida Health. Dialysis vin-
tage was counted as months from the commencement of
any form of dialysis. All numerical data were expressed
in unaltered form over the 2 years and as cross-sectional
means for evaluation of temporal relationships within
each 4-month period over the 2 years (58 variables × 57
patients × 24 months).
Statistical analysis
The analysis was done using PASW/18 (2009 SPSS Inc.)
and the variables expressed as means ± SD. p < 0.05 was
considered to be significant. The relationship between
serum albumin as a continuous (scaled) variable and each
of the independent numerical variables was studied using
the Pearson Correlation Coefficient; the strength of this
association was then tested using multiple regression
including other covariates and the attributable impact of
each independent variable on mean serum albumin levels
was calculated as the coefficient beta (standardized for the
varied units used to measure the 11 non-demographic
variables) with 95% confidence intervals (CI). A 2 × 2 table
was used to study the impact of gender and diabetes melli-
tus on the number of instances of albumin < 3.8 g/dl by
calculating the likelihood ratio using Chi-square tests with
continuity correction. Binary Logistic Regression (BLR)
was used for multi variable relationships with serum albu-
min levels of <3.8 g/dl as the categorical outcome variable
and the likelihood ratio of each independent variable
(exponent B) derived with 95% CI; the significance of the
results was calculated with and without bootstrapping of
1000 sample iterations across variables in an effort to
make the analysis robust. Temporal relationships between
serum albumin and nPCR (as a measure of protein intake)
and serum ferritin (which correlates negatively with serum
albumin) were studied using Pearson’s correlation with
data submitted to analysis as continuous and 4-monthly
cross-sectional means respectively; the 24 month period
was divided into 6 blocks of 4 months each because serum
ferritin was measured only once every 4 months by unit
policy necessitated by CMS reimbursement. Erythrocyte
sedimentation rates and C-reactive protein levels were not
routinely available for the 57 patients over the 24 months
studied, again determined by standard reimbursement
related policies. The specific impact of a given month’s
mean nPCR on the mean serum albumin levels of the
concurrent and 3 subsequent months was expressed as
the F statistic with 3 degrees of freedom for 4 methods of
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trace and Roy’s largest root. Finally, multinomial regres-
sion was used to study the impact of each factor shown to
be significant by Pearson correlation on a range of out-
come albumin levels to double check the impact of nPCR,
the independent variable of interest, at each cut-off point
of albumin from 1.9 through 4.1 g/dl.
Results
Of the 57 patients 26 were male and 31 were female.
The median age was 57 years (range 29 to 85 years) and
the mean 58 years. The causes of renal failure included
the following: diabetic nephropathy (n = 27), primary
hypertensive renal disease (n = 17), chronic glomerulo-
nephritis (n = 9), unknown etiology (n = 7) and obstruct-
ive pyelonephritis (n = 1).
The mean values of the clinical and dialysis data, serum
biochemistry results, and potential contributors to hypo-
albuminemia of 57 patients are given in Table 1.
Univariate analysis
An inverse correlation was found between age and mean
serum albumin (p < 0.001). Advancing age associated
with lower albumin (especially in women (Figure 1) and
in both diabetics and non-diabetics (Figure 2) except in
the 9th decade in which there were only 5 diabetics who
had a higher mean albumin level than their 18 non-
diabetic counterparts among our patients, mainly due to
the values of 2 patients. Of the continuous variables
nPCR (Figure 3), % change in post-HD goal (dry) weight,Table 1 Clinical, dialysis and laboratory data in 57
hemodialysis patients and co-morbid features predisposing
to hypoalbuminemia
Parameter Mean ± SD
Age (yrs) 57.9 ± 14.6
Dialysis vintage (mo) 47.8 ± 38.6
BMI (kg/sq.m) 30.2 ± 10.9
Albumin(g/dl) 3.38 ± 0.40
Ferritin (ng/ml) 623.57 ± 356.04
nPCR 1.01 ± 0.33
Phosphate (mg/dl) 5.69 ± 1.91
URR% 73.96 ± 19.99
WBC (1000/cmm) 6.72 ± 2.32
Comorbid Features n
Catheter use (6–24 months) 18
Coronary disease 12
Peripheral vascular disease 08
CHF (systolic +/− diastolic) 10
CHF (diastolic alone) 06
Malignancy 05serum phosphate were positively correlated with mean
serum albumin levels (p < 0.001 for all) whereas the
number of episodes of bacteremia (p < 0.001), febrile epi-
sodes, and days spent in hospital (p < 0.05 for both)
showed a negative correlation with mean albumin levels.
Dialysis vintage, % URR, and ferritin did not show a cor-
relation with mean albumin (Table 2). Female and dia-
betic patients were more likely to have a serum albumin
<3.8 g/dl (Table 3).
Multivariate analysis
Multiple linear regression (Table 4) showed that mean
serum albumin as the outcome variable was most sig-
nificantly impacted by age, diabetes mellitus, hospital
stay, and bacteremia (p</=0.005); and to a smaller
degree of significance by gender , vintage , and nPCR
(p < 0.05 for each). Binary logistic regression (BLR)
showed that advanced age, female sex, and diabetes
mellitus conferred the greatest hazard of a serum albu-
min <3.8 g/dl (p</=0.008) followed by nPCR, dialysis
vintage, and ferritin (p < 0.05). Serum phosphate and %
URR did not appear to impact either the mean or the
target albumin levels by BLR (Table 5).
The albumin levels of any 4 consecutive months did
not significantly differ from each other or the index
month by ANOVA. The effect of nPCR of the index
month on mean albumin in any of the four subsequent
months was not significantly different than on that of the
index month: the exact statistic (F) for albumin being 0.572
for each of the 4 months in any temporal segment
(p = 0.63) and the within-subjects-design (intercept) against
nPCR of month 0 (index month) for each segment was
0.641 (p = 0.58). Thus we were not able to demonstrate any
longitudinal pattern of variation in the albumin levels rela-
tive to nPCR of any given month.
Multinomial regression demonstrated the impact of
nPCR at each level of increment of albumin of 0.1 g/dl
from 1.9 to 4.1 g/dl when fever, days in hospital,
bacteremia, and dry weight change, age (decile), sex, phos-
phorus, and WBC counts, the factors shown by Pearson
correlation to be significant or nearly significant, were
taken into account (p < 0.001).
Discussion
This retrospective analysis suggests that the suggested
serum albumin targets were not met in the elderly and
diabetic patients, particularly women and that there was
a significant association between mean albumin and
nPCR (protein intake) which was not nullified by con-
founding non-nutritional factors. Such hypoalbuminemia
is known to unfavorably alter prognosis [17-20].
Recent publications have confirmed an association of
serum albumin and mortality though some have ques-
tioned its value as a nutritional marker [11,12,15,21]
Figure 1 Serum albumin by gender and decile of age.
Figure 2 Serum albumin by age decile and diabetic status.
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Figure 3 Relationship between nPCR and mean serum albumin.
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to be associated with a reduction in its levels, most likely
due to catabolism [22]. Hypoalbuminemia is associated
with hypotension [23], progressive left ventricular dys-
function [24] and reduced intra-dialytic skin blood flow
[25] and is due to decreased synthesis; attempts to cor-
rect hypoalbuminemia have not resulted in improved
mortality so far [26-37].Table 2 Correlation between mean 4 monthly serum
albumin and risk factors
Pearson coefficient p
Age in years −0.25 <0.001
Vintage in months 0.05 0.35
nPCR 0.31 <0.001
% Goal Weight Change 0.23 <0.001
Serum Phosphate (mg/dl) 0.22 <0.001
%URR 0.03 0.55
Episodes of fever −0.11 0.02
Leukocytes /cmm −0.09 0.07
Ferritin (ng/ml) 0.02 0.64
Bacteremia (episodes) −0.27 <0.001
Days in hospital −0.13 0.01
P < 0.05 = significant.Age, sex, catheter use, nPCR, creatinine, dialysis
adequacy, WBC number, neutrophil:lymphocyte ratio,
C-reactive protein, hemoglobin and aspartate amino-
transferase(AST) level are associated with albumin
levels in the serum [27-29]. Advanced age (>65 years)
is associated with lower serum albumin in large cross-
sectional studies [38,39]. We used age as a continuous
and ordinal variable and found a correlation with hy-
poalbuminemia in both men and women (Tables 2).
Reductions in dietary protein and energy intake appear
to be the likely reasons for hypoalbuminemia in the
elderly [40,41]. Our results confirm a direct, and some-
what robust association between protein intake (nPCR)
and serum albumin similar to the results of others
[42-45] . Investigators studying a small series of patients
found a catabolic state when the dietary protein intake
was 42.5 g/d (nPCR, 0.78 g/kg/d) and an anabolic state
when the dietary protein intake was 73.5 g/d (nPCR,
0.88 g/Kg/d) in a prospective cross-over trial confirming
an association between dietary protein intake and nPCR
in hemodialyzed patients [46]; the MDRD study in pre-
ESRD patients showed similar results [47]. As described
in the literature [48], advancing age, female sex, and the
presence of diabetes were associated with a greater haz-
ard of hypoalbuminemia in our patients. Unlike some in-
vestigators [49] we did not find a stronger relationship
between albumin and indicators of inflammation (ferritin,
Table 3 2 x 2 Table for risk of hypoalbuminemia by gender and diabetes
Alb >3.8 g/dl Instances (%) Alb <3.8 g/dl Instances (%) Total (%)
Gender (*) Female 13 (7) 173 (93) 186 (100)
Male 35 (22.4) 121 (77.6) 156 (100)
Diabetes(#) Present 6 (3.6) 161 (96.4) 167 (100)
Absent 42 (24) 133 (76) 175 (100)
* Likelihood ratio (Chi-square with continuity correction) of instances of albumin <3.8 in female patients = 17.08 (asymptotic p < 0.001).
# Likelihood ratio (Chi-square with continuity correction) of instances of albumin <3.8 g/dl in diabetics = 27.8 (asymptotic p < 0.001).
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(nPCR) and serum phosphate. The relationship of albu-
min and nPCR remained highly significant after discount-
ing the effect of phosphate levels in our group of patients
using partial correlation (p < 0.001) and multi-variable
methods (p = 0.01) consistent with the experience of other
investigators [50]. Mortality is associated with lower
serum albumin levels and nPCR in well dialyzed patients
[51,52] and dietary phosphate intake and dietary phos-
phate to protein ratio have been shown to have an adverse
effect on mortality in a recent study [53]. Zitt et al. in a
prospective cohort study (INVOR) found a higher risk of
mortality when the albumin and phosphate were both low
or high than when the phosphate levels were low and
those of albumin high [54]. However, prescribed dietary
phosphate restriction was associated with higher mortality
when time-dependent confounders were included in a
post hoc analysis of the Hemodialysis Study whose
authors postulate that phosphate-rich foods tend to be
nutrient dense and presumably protein-rich [55]. Serum
phosphate levels may reflect this greater nutrient intake








WBC x 1000/cmm −0.044
Weight change% 0.043
Fever 0.097





Age in years −0.175
* = Significant.of hyperparathyroidism would also impact them. A sur-
prising lack of association was noticeable between serum
albumin and small solute clearance as indicated by % URR
in our patients. We attribute this finding to our unit policy
that dictated the use of dialyzers with higher urea clear-
ance, increasing dialysis time and blood flow rates when
KT/V was <1.4 which resulted in few instances of under-
dialysis. We used URR % (which is mandated by CMS) be-
cause many dialysis facilities do not routinely calculate
KT/V and the latter is intrinsically related to nPCR. A lack
of association of weight loss (as indicated by changes in
the post dialysis goal weight) with serum albumin levels
<3.8 g/dl was seen due to an insufficient number of in-
stances of weight loss during the study period; however,
there was a correlation between such goal weight changes
and mean serum albumin (Tables 2 & 4). Dry weight is de-
termined by nephrologists by clinical trial and error with
the attendant pitfalls when used for analysis. We did not
find an association between baseline dry weight and albu-
min or inflammatory markers [56,57]. We did not analyze
inter-dialytic weight gain vs. albumin change in our study;
others have observed a negative effect of lower interdialytictors on mean serum albumin
95% CI 95% CI 2-tailed p
Lower Upper
2.713 3.728 0.001 *






−0.013 0.138 0.036 *
−0.022 −0.007 0.001 *
−0.286 −0.035 0.005 *
−0.002 −5.187 0.035 *
0.005 0.146 0.044 *
−0.185 −0.046 0.004 *
−0.006 −0.002 0.001 *
Table 5 Results of binary logistic regression: serum albumin < 3.8 vs. risk factors
95% CI
Factor LR (exp B) Lower Upper p p (with bootstrapping)
Age in years 1.029 1.000 1.059 0.051 * 0.008 *
Female Sex 3.684 1.566 8.667 0.003 * 0.001 *
Diabetes mellitus 0.137 0.049 0.381 <0.001 * 0.001 *
Vintage (months) 0.992 0.982 1.002 0.103 0.057
%URR 1.006 0.927 1.092 0.878 0.870
nPCR 0.232 0.051 1.045 0.057 0.043 *
Serum Phosphate 0.912 0.689 1.208 0.521 0.447
%Weight Loss 1.082 0.980 1.194 0.119 0.128
Days in Hospital 1.042 0.926 1.174 0.492 0.470
Febrile Episodes 1.502 0.413 5.456 0.537 0.501
Bacteremia 0.982 0.248 3.891 0.979 0.962
Leukocytosis 0.955 0.766 1.190 0.682 0.696
Serum Ferritin 0.999 0.997 1.000 0.064 0.047 *
* = significant. LR = Likelihood Ratio. Bootstrapping performed with 1000 iterations.
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tudinal analyses [57]. Dialysis vintage is associated with a
higher relative risk of death in case-mix adjusted analyses
independent of nutritional and other variables in larger
cohorts [58]. Vintage appeared to be associated with albu-
min < 3.8 g/dl in our patients only by univariate methods,
and was of borderline significance in multivariate analyses,
but did not correlate with mean serum albumin. Inflamma-
tion and dietary protein intake are known to impact serum
albumin in opposing ways [59]. One effect of the chronic
inflammatory state in dialysis patients is sustained hypoal-
buminemia according to the HEMO Study [60]. Serum
ferritin is measured routinely in most U.S dialysis units to
guide intravenous iron therapy, and is a surrogate for in-
flammation that associates with short term mortality and
hypoalbuminemia [61]; it appeared to correlate with albu-
min <3.8 g/dl in our study. Hospitalization is associated
with malnutrition in general, and protein malnutrition
in particular, even in well dialyzed patients [53,62] and
correlates with weight loss, reduction in albumin, and in-
flammation, particularly when the stay is prolonged and
caused by inflammatory conditions [63]; we did not find a
correlation of hospital stay with albumin <3.8 g/dl but it
was negatively associated with mean albumin levels. The
bromocresol purple method of albumin measurement
which gives slightly lower levels is closer to the gold stand-
ard of immunonephelometry and may provide value to
our data [64,65].
Limitations of the study
This was a retrospective analysis of patient data with the
attendant pitfalls. Residual renal function (which can
lower nPCR) was not studied because there were only a
few patients who were not oliguric and 24 hour urinedeterminations were not available. Such residual function
would likely inflate, not diminish, the impact of nPCR on
albumin. We were not able to demonstrate any longitu-
dinal pattern of variation in the albumin levels relative to
nPCR of any given month. Also, observation of the data
suggested a relatively small number of instances of hos-
pital stay and positive blood culture; this could have
diminished the demonstrated impact of inflammation.
C-reactive protein and pre-albumin levels would have
provided valuable information and were not available and
are not generally measured in U.S dialysis units routinely.
Conclusions
Protein intake as measured by nPCR correlates with
serum albumin even when confounding factors are taken
into account. Prospective studies are required to confirm
whether albumin targets would be difficult to achieve in
elderly female diabetics and whether protein supplemen-
tation would alter albumin levels in such vulnerable
subgroups.
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